Literature DB >> 18284462

Prevalence, detection and drug treatment of hypertension in a rural Australian population: the Greater Green Triangle risk factor study 2004-2006.

E D Janus1, S J Bunker, A Kilkkinen, K Mc Namara, B Philpot, P Tideman, R Tirimacco, T K Laatikainen, S Heistaro, J A Dunbar.   

Abstract

BACKGROUND: Hypertension is an important risk factor for cardiovascular disease; however, limited findings are available on its detection and management in rural Australia. AIM: To assess the prevalence, awareness and treatment of hypertension in a rural South-East Australian population.
METHODS: Three cross-sectional surveys in Limestone Coast, Corangamite Shire and Wimmera regions during 2004-2006 using a random population sample (n = 3320, participation rate 49%) aged 25-74 years. Blood pressure was measured by trained nurses. Information on history of hypertension and medication was obtained by questionnaires. Hypertension was defined as systolic blood pressure >or=140 mmHg and/or diastolic blood pressure >or=90 mmHg and/or on antihypertensive drug treatment.
RESULTS: Overall, one-third of participants had hypertension; of these, two-thirds, 54% (95% confidence interval (CI) 47-60) of men and 71% (95% CI 65-77) of women, were aware of their condition. Half of the participants with hypertension were treated and nearly half of these were controlled. Both treatment and control were more common in women (60%, 95% CI 54-67 and 55%, 95% CI 47-64) compared with men (42%, 95% CI 36-49 and 35%, 95% CI 26-44). Monotherapy was used by 55% (95% CI 48-61) of treated hypertensives. Angiotensin-converting enzyme inhibitors were the most frequently used class of antihypertensive drugs in men, whereas angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists and diuretics were all widely used among women.
CONCLUSION: This study emphasizes suboptimal detection and treatment of hypertension, especially in men, in rural Australia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18284462     DOI: 10.1111/j.1445-5994.2007.01583.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  15 in total

1.  Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.

Authors:  Yuichi Tasaka; Daiki Yasunaga; Mamoru Tanaka; Akihiro Tanaka; Takashige Asakawa; Ikuo Horio; Yoshiro Miyauchi; Hiroaki Araki
Journal:  Int J Clin Pharm       Date:  2016-01-08

2.  Patients' Attitudes and Approaches to the Self-Management of Hypertension: Perspectives from an Australian Qualitative Study in Community Pharmacy.

Authors:  Beata Bajorek; Kate Lemay; Parker Magin; Christopher Roberts; Ines Krass; Carol Armour
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-02-06

3.  Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial.

Authors:  Rosalind Lau; Kay Stewart; Kevin P McNamara; Shane L Jackson; Jeffery D Hughes; Gregory M Peterson; Diana A Bortoletto; Jenny McDowell; Michael J Bailey; Arthur Hsueh; Johnson George
Journal:  BMC Health Serv Res       Date:  2010-02-05       Impact factor: 2.655

4.  Challenges in measuring medication adherence: experiences from a controlled trial.

Authors:  Kay Stewart; Kevin P Mc Namara; Johnson George
Journal:  Int J Clin Pharm       Date:  2014-02

5.  Hypertension: What are the self-care and health-care-seeking behaviours in women over time?

Authors:  D Sibbritt; P Davidson; W B Peng; J Adams; L Hickman
Journal:  J Hum Hypertens       Date:  2016-04-28       Impact factor: 3.012

6.  Hypertension prevalence, awareness, treatment and control, and associated factors: results from a national survey, jordan.

Authors:  H Y Jaddou; A M Batieha; Y S Khader; A H Kanaan; M S El-Khateeb; K M Ajlouni
Journal:  Int J Hypertens       Date:  2011-12-01       Impact factor: 2.420

7.  A comparison of Australian rural and metropolitan cardiovascular risk and mortality: the Greater Green Triangle and North West Adelaide population surveys.

Authors:  Philip Tideman; Anne W Taylor; Edward Janus; Ben Philpot; Robyn Clark; Elizabeth Peach; Tiina Laatikainen; Erkki Vartiainen; Rosy Tirimacco; Alicia Montgomerie; Janet Grant; Vincent Versace; James A Dunbar
Journal:  BMJ Open       Date:  2013-08-23       Impact factor: 2.692

8.  Assessing cardiovascular risk in regional areas: the Healthy Hearts Beyond City Limits program.

Authors:  Melinda J Carrington; Garry L Jennings; Robyn A Clark; Simon Stewart
Journal:  BMC Health Serv Res       Date:  2012-09-03       Impact factor: 2.655

9.  Preparing pharmacists to deliver a targeted service in hypertension management: evaluation of an interprofessional training program.

Authors:  Beata V Bajorek; Kate S Lemay; Parker J Magin; Christopher Roberts; Ines Krass; Carol L Armour
Journal:  BMC Med Educ       Date:  2015-09-28       Impact factor: 2.463

Review 10.  The determinants and scope of public health interventions to tackle the global problem of hypertension.

Authors:  Saurabh RamBihariLal Shrivastava; Prateek Saurabh Shrivastava; Jegadeesh Ramasamy
Journal:  Int J Prev Med       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.